Request Deal Involvement

Lightspeed Venture Partners and Ascenta Capital led a $175 Series C round in Alpha-9.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

DELOS CAPITAL

bidder

DELOS CAPITAL

DIGITALIS VENTURES

bidder

DIGITALIS VENTURES

ALPHA-9 THERANOSTICS

target

ALPHA-9 THERANOSTICS

LIGHTSPEED VENTURE PARTNERS

bidder

LIGHTSPEED VENTURE PARTNERS

ASCENTA CAPITAL

bidder

ASCENTA CAPITAL

A16Z BIO + HEALTH

bidder

A16Z BIO + HEALTH

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

LUMIRA VENTURES

bidder

LUMIRA VENTURES

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

FRAZIER LIFE SCIENCES

bidder

FRAZIER LIFE SCIENCES

BVF PARTNERS

bidder

BVF PARTNERS

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

SHELLEY CHU

bidder

SHELLEY CHU

NEXTECH INVEST

bidder

NEXTECH INVEST

EVAN RACHLIN

bidder

EVAN RACHLIN

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite